Source:http://linkedlifedata.com/resource/pubmed/id/17674414
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2007-10-1
|
pubmed:abstractText |
Because of the occurrence of different types of mutations, comprehensive genetic testing for Parkinson's disease (PD), dopa-responsive dystonia (DRD), and myoclonus-dystonia (M-D) should include screening for small sequence changes and for large exonic rearrangements in disease-associated genes. In diagnostic and research settings, the latter is frequently omitted or performed by laborious and expensive quantitative real-time PCR (qPCR). Our study aimed to evaluate the utility of a novel method, multiplex ligation-dependent probe amplification (MLPA), in molecular diagnostics of movement disorders. We have analyzed, by MLPA, genomic DNA from 21 patients affected with PD, DRD, or M-D, in which the presence of exon rearrangement(s) (n = 20) or of a specific point mutation (detectable by MLPA, n = 1) had been established previously by qPCR or sequencing. In parallel, we have studied, in a blinded fashion, DNA from 49 patients with an unknown mutational status. Exon rearrangements were evident in 20 samples with previously established mutations; in the 21st sample the known specific point mutation was detected. We conclude that MLPA represents a reliable method for large-scale and cost-effective gene dosage screening of various movement disorders genes. This finding reaches far beyond a simple technical advancement and has two major implications: (1) By improving the availability of comprehensive genetic testing, it supports clinicians in the establishment of a genetically defined diagnosis; (2) By enabling gene dosage testing of several genes simultaneously, it significantly facilitates the mutational analysis of large patient and control populations and thereby constitutes the prerequisite for meaningful phenotype-genotype correlations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0885-3185
|
pubmed:author |
pubmed-author:BeetzChristianC,
pubmed-author:DjarmatiAnaA,
pubmed-author:GrünewaldAnneA,
pubmed-author:Guzvi?MiodragM,
pubmed-author:HedrichKatjaK,
pubmed-author:KaindlAngela MAM,
pubmed-author:KleinChristineC,
pubmed-author:LangAnthony EAE,
pubmed-author:NygrenAnders O HAO,
pubmed-author:PramstallerPeter PPP,
pubmed-author:SimonDavid KDK,
pubmed-author:ViereggePeterP
|
pubmed:copyrightInfo |
(c) 2007 Movement Disorder Society.
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1708-14
|
pubmed:meshHeading |
pubmed-meshheading:17674414-Exons,
pubmed-meshheading:17674414-Gene Rearrangement,
pubmed-meshheading:17674414-Humans,
pubmed-meshheading:17674414-Movement Disorders,
pubmed-meshheading:17674414-Nucleic Acid Amplification Techniques,
pubmed-meshheading:17674414-Polymerase Chain Reaction,
pubmed-meshheading:17674414-Reproducibility of Results
|
pubmed:year |
2007
|
pubmed:articleTitle |
Rapid and reliable detection of exon rearrangements in various movement disorders genes by multiplex ligation-dependent probe amplification.
|
pubmed:affiliation |
Department of Neurology, University of Lübeck, Lübeck, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|